Markets Gone Wild

Investigation Commenced by Levi & Korsinsky into Pliant Therapeutics, Inc. Regarding Alleged Securities Law Violations On February 25, 2025, Levi & Korsinsky, a prominent securities law firm, announced the initiation of an investigation into Pliant Therapeutics, Inc. (NASDAQ: PLRX) over potential securities law violations. The investigation comes in the wake of the biotech company’s announcement…

Understanding Your Rights as an IIPR Investor: A Comprehensive Guide New York, NY – If you’ve recently experienced losses on your investment in Innovative Industrial Properties, Inc. (IIPR) and are seeking information about potential recovery under the federal securities laws, this article is here to help. In this comprehensive guide, we will walk you through…

Springbig’s Acquisition of VICE CRM: A Game-Changer in SaaS-Based Marketing Solutions BOCA RATON, Fla., March 17, 2025 – Springbig Holdings, Inc., a pioneering provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs, has recently announced the acquisition of VICE CRM. This AI-enabled performance marketing platform is designed to optimize return on…

Two Popular Dividend ETFs: Vanguard High Dividend Yield ETF (VYM) and Vanguard Dividend Appreciation ETF (VIG) Investing in exchange-traded funds (ETFs) that focus on dividend-paying stocks can be an excellent strategy for generating consistent income. Two of the most popular dividend ETFs in the market are the Vanguard High Dividend Yield ETF (VYM) and the…

Teva Pharmaceuticals and Medincell’s Collaboration: A New Treatment Option for Bipolar I Disorder In a recent press release, Teva Pharmaceuticals, an American subsidiary of Teva Pharmaceutical Industries Ltd., and Medincell, a French biotech company, announced that the supplemental New Drug Application (sNDA) for Uzedy, an extended-release injectable suspension, has been accepted for filing by the…

Conavi Medical Corp. Announces Strategic Partnership with BND Projects Inc. Toronto, Canada, February 4, 2025 – Conavi Medical Corp. (TSXV: CNVI), a leading commercial-stage medical device company specializing in the design, manufacturing, and marketing of imaging technologies for common minimally invasive cardiovascular procedures, is thrilled to announce a new Corporate Development and Strategic Services agreement…

Mustang Bio Regains Compliance with Nasdaq Listing Rule WORCESTER, Mass., Feb. 11, 2025 – Mustang Bio, Inc. (Mustang), a clinical-stage biotechnology company focused on translating today’s medical breakthroughs into tomorrow’s cures for rare and complex diseases, is pleased to announce that it has received notice from The Nasdaq Stock Market LLC (Nasdaq) indicating that the…